Deletions of highly, but not entirely, homologous intragenic sequence repeats result in amino acid sequence and conformational changes in the M proteins of spontaneous M protein-size variants of group A streptococci. To determine if antigenic changes occurred as a result of these deletion mutations, monoclonal and polyclonal antibodies with defined epitopes were used in competition assays. Competing antigens were either purified pepsin-derived fragments (representing the amino-terminal half of the molecule) of parent and mutant M proteins or wier intact bacterial cells. These assays showed that antigenic variation occurred at the site(s) of these deletions but not at adjacent or distant epitopes. Once cleaved from the bacterium by pepsin, the M molecules also underwent conformational changes, which were reflected in their ability to compete. A monoclonal antibody opsonic for M6 streptococci lost its ability to completely opsonize one of the size mutants in this study. Therefore, spontaneous intragenic events between repeats within emm-6, the structural gene for the M6 protein, do result in structural variations within the mutant M molecules. This variation alters the ability of certain antibodies, originally produced in response to sequences in the parental M molecule, to bind to the mutant M molecules or opsonize the mutant organisms. Group A streptococci have evolved a mechanism for generating antigenic diversity that differs from currently known mechanisms in other bacterial species.
M protein serves as the primary virulence factor for group A streptococci by virtue of its antiphagocytic nature (1) . For each of the 80 + antigenically different M serotypes found among group A streptococcal isolates, only type-specific opsonic antibodies directed against this molecule have been shown to clear the organism from the infected host (2) . M protein is a fibrous molecule extending about 60 nm from the cell surface, which exists as a dimer of a-helices arranged in a coiled-coil, rope-like structure (3, 4) . The DNA sequence of the structural gene of the M6 protein from strain D471 (emm-6.1) revealed the presence of regions of extended repeats at the nucleotide level (5) . When translated, the sequence disclosed four distinct amino acid sequence repeat regions. Region A (residues 27-96) and region B (residues 110-230), consisting of five tandem repeats of 14 and 25 amino acids each, respectively, have three identical central repeats and two slightly divergent flanking repeats; the C repeat region consists of two and a half tandem repeats of 42 residues each, starting at residue 231, but is not as homologous as the A or B repeat regions; a D repeat region includes four tandem 7-residue "quasi-repeats" (5, 6) . The number of such repeats varies among M proteins of different serotypes for which sequence data is currently available (7) (8) (9) .
Antigenic variation is the means by which many bacterial pathogens are able to escape immune clearance by the host. However, the molecular mechanisms for this variation have been studied in depth in relatively few bacterial protein antigen systems (10) (11) (12) . Recently, we demonstrated the phenomenon of size variation among M proteins of different serotypes and among M proteins within the same M serotype of group A streptococci (13) . Subsequently, size variation was observed in the M6 protein of spontaneous laboratory mutants; which occurred at high frequency (5 x 10-4 per colony-forming unit) (14) . The changes in these and other size variants resulted from duplication or deletion of homologous intragenic tandem sequence repeats within the single emm-6.1 gene (the A, B, and C repeat regions; ref. 15) . It has been hypothesized, but not yet proven, that the changes resulting from these recombinational events lead to antigenic variation in these proteins and are thereby part of the evolutionary mechanism used by these organisms in their attempts to escape immune clearance.
Using antibodies raised against synthetic peptides and monoclonal antibodies with defined epitopes within the parental M protein, this investigation explores the antigenic changes that have occurred in spontaneous M protein-size mutants derived from the parent strain.
MATERIALS AND METHODS
Bacterial Strains. Strain D471 is an M type 6 group A streptococcus from the Rockefeller University culture collection. Strains D471d112 (d112) and D471d113 (d013) are M protein deletion mutants derived directly from strain D471 and have been described partially (6, 14, 15) . The convention agreed upon by an international committee to designate alleles of the emm gene and different M proteins will be used in this paper. In this system, emm-6.J is the allele present in D471, and the protein from this organism is M6.1; emm-6.4 is the allele of strain d112, and its protein is M6.4; and emm-6.5 is the allele of strain d113, and its protein is M6.5.
Production of Monoclonal Antibodies (mAbs). mAbs against either the phage lysin-extracted M6 protein or the native M6 protein as derived from Escherichia coli carrying the structural gene for this molecule (ColiM6.1) were produced as described (16, 17) . The positions of the epitopes for mAbs 3B8 and 10All relative to the native M6.1 protein are shown in Fig. 1 purified, and characterized as described (18) . Antisera were raised to synthetic peptides coupled to ovalbumin as described (18) .
Competition ELISA. Competition of purified proteins or whole bacterial cells for the binding of various antibodies to ColiM6.1 was performed by the competition ELISA method described by Jones et al. (17) . ColiM6.1 was isolated and purified as described (19 Gamier et al. (20) and has been partially reported (6) .
Extraction and Purification of Pepsin-Derived Fragments of M Protein (PepM). M proteins were extracted and purified from strains D471, d112, and d113 by limited pepsin hydrolysis by the method of Beachey et al. (21) with modifications by Manjula and Fischetti (22) . Purity was determined at each step by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and immunoblotting as described (19) .
Bactericidal Assay. Antibodies were assayed for their ability to opsonize strains D471, d112, or d113 by the indirect
M6. 5 bactericidal assay as described (2) A0 . This rearrangement resulted in a lysine-for-asparagine switch at residue 40 (like M6.4); in addition, the lysine at residue 34 is replaced with asparagine in M6.5 ( Figs. 2 and 3 ). Conformational analysis revealed that, as a result of these deletions, M6.4 became a much more helical molecule than M6.1, whereas M6.5 still retained much of the turn potential of the parental M6.1 protein (Fig. 3) (6) .
Antigenic Variation in Purified Size-Variant M Proteins. Competition assays were used to determine whether the sequence and/or conformational changes seen in the M6 protein-size mutants affected the antigenicity of these proteins at specific sites by using antibodies raised either to the parental molecule or sequeiices derived therefrom. Purified pepsin-extracted M protein fragments from these strains served as competitors (Fig. 4A ). These proteins, PepM6.1 (from parental strain D471), PepM6.4 (from mutant d112), 
Alignment of the amino acid sequences of the M proteins from parent D471 (M6.1) and M protein-size mutants d112 (M6.4) and d113 (M6.5) through the amino-terminal 119 residues (of D471). The epitopes for antibodies used in the competition assays (see Fig. 4 Figs. 1 and 2) .
The competition for antibodies binding to the first 32 residues [anti-S-M6-(1-21) and anti-S-M6-(13-32)] did not vary appreciably among these three strains (Fig. 4) . At the anti-S-M6-(29-37) site, where M6.5 has an amino acid different from M6.1 and M6.4 (residue 34), competition by the corresponding pepsin-derived fragment, PepM6.5, was nearly abolished. As expected, there was little apparent difference in the abilities of PepM6.1 and PepM6.4 to compete for the binding of this antibody to ColiM6.1.
The epitopes for mAb 3B8 (residues 41-46, 55-60, and 69-74) and anti-S-M6-(53-66) [repeated at residues 39-52 (with a substitution at residue 40) and 67-80] are present three times in PepM6.1 but only once in PepM6.4 and PepM6.5 (Fig. 2) . However, competition with these three proteins does not follow a 3:1 ratio, as might be expected. When mAb 3B8 was used, the ability of PepM6.4 to compete decreased -53 times from that of the parent PepM6.1, while PepM6.5 was less efficient in competition assays than PepM6.1 by a factor of 5. With anti-S-M6-(53-66), PepM6.4 competed slightly better than PepM6.5, but PepM6.1 was 20-30 times more efficient at competition than either of them. Clearly, the amino acid alterations at residue 34 (in PepM6.5) and 40 (in PepM6.4 and PepM6.5) caused more of an antigenic change than could be accounted for by the differences in the number of epitopes present in these three proteins at this site. With anti-S-M6-(95-108) or mAb lOA11 that react with sites removed from the changes caused by these deletions, the (Fig. 4B) .
As with the purified proteins, there was no significant difference among the three strains to compete for the aminoterminal antibody, anti-S-M6 (1-21) . With (18) and are the only antibodies with defined epitopes that have proved to be opsonic for this strain. Since antigenic variation occurred at the mAb 3B8 binding site in the mutant M proteins (particularly that of M6.4 on d112), it seemed likely that these alterations would affect the ability of this antibody to opsonize the mutant cells. To test this hypothesis, anti-S-M6-(1-21) and mAb 3B8 were examined in bactericidal assays for their relative opsonic potential with parental strain D471 and mutants d112 and d113 (Fig. 5) .
Although some apparent variation was observed in the ability of anti-S-M6-(1-21) to opsonize these three strains (Fig. 5A) , it was not significant. However, there was a dramatic decrease in the ability of mAb 3,B8 to opsonize d112 cells relative to D471 and d113 (Fig. SB) . This result agrees with the diminished ability of strain d112 to compete for mAb 3B8 binding in competition assays (Fig. 4) . D471 and d113 are opsonized equally well by this mAb despite the appearance of the 3B8 epitope three times in M6.1 of D471 vs. once in M6.5 of d113 (Fig. 2) and the fact that d113 cells competed better for mAb 3B8 binding than did D471 (Fig. 48) . (i.e., at residues 34 and/or 40) was affected in the mutants, as demonstrated by competition assays with anti-S-M6-(29-37), mAb 3B8, and anti-S-M6(53-66). The greatest effect was seen when the recombination event involved a nonidentical repeat segment resulting in a sequence change at the binding site for anti-S-M6-(29-37) (Fig. 4) (1988) sequence three times in M6.1 but only once each in M6.4 or M6.5. Thus, the differences in competition among these three strains were more likely due to the relative number of epitopes per M molecule rather than to changes in the sequence recognized by this antibody. This differs from the data for mAb 3B8, which has its epitopes within the repeated S-M6-(53-66) sequence (see Fig. 2 ) but reacted quite differently with the three strains. This suggests that anti-S-M6-(53-66) recognizes different epitopes than does mAb 3B8 and that the anti-S-M6-(53-66) epitopes were not affected by the amino acid changes at residues 34 and 40 in the mutant proteins present on intact organisms. This difference may be explained by current evidence indicating that the mAb 3B8 epitopes may be conformationally dependent (unpublished data).
Anti-S-M6-(1-21) showed little variation in its ability to opsonize the parent D471 or the two mutant derivatives. However, mAb 3B8 showed a marked decrease in its ability to opsonize mutant strain d112. It seems likely that despite the amino acid changes at residues 34 and 40 in M6.5, its conformation more closely approximates that of the parent M6.1 than does M6.4 from d112 with only one change at residue 40 (see Fig. 3 ). In mutant d112, two repeat segments containing two of the three mAb 3B8 epitopes were deleted, resulting in a conformational change in the remaining 3B8 epitope adjacent to the deleted region. Thus, this conformational change has altered the opsonic potential of the 3B8 antibody, enabling this mutant to increase its chances of survival in an immune environment containing only this antibody.
The mechanisms for antigenic variation in other bacterial surface proteins have been described (10) (11) (12) . In the gonococci, silent partial pilin genes undergo homologous recombination with the complete pilin gene in the expression site, thereby producing antigenically new pilin molecules (10) . Gonococci apparently use a similar mechanism to alter the antigenicity of the outer membrane protein II. In this case, hypervariable regions of the multiple protein II genes may recombine with each other. Then, when a particular protein II gene is expressed, antigenically novel proteins II may be produced (11) . In Borrelia, antigenic variation of the variable major protein (VMP) involves gene replacement of an entire inactive VMP coding gene into the expression site of a different VMP gene (12) . Both the gonococci and Borrelia, then, require new information from outside the expression site of these surface protein genes to generate their antigenic diversity. Conversely, most group A strains have only one emm homologous region in their genome (24) , so antigenic diversity cannot be produced by extragenic replacement events. Instead, the group A streptococci have evolved an M protein gene sequence that allows generation of antigenic diversity by intragenic rearrangements (15) .
Antigenic variation of gonococcal pili and Borrelia VMP may be required for the persistence of these organisms in the infected host for months (12, 25) . However, group A streptococcal pharyngitis is a self-limiting disease, lasting up to 14 days. By this time, opsonic antibodies are produced to the M protein, which allow for clearance of the infecting organisms (2). More than one opsonogenic epitope is present in the amino-terminal region of the M molecule, and antibodies to only one epitope are sufficient to allow for opsonization and phagocytosis of the streptococcus (18, (26) (27) (28) . In the gonococcus and Borrelia, antigenic changes in the protective surface proteins result from the exchange of large blocks of genetic information (10, 12) , whereas in the streptococcus the alteration is limited to only a few amino acids. Thus, M protein mutants produced during a streptococcal infection may not be sufficiently altered in all opsonogenic epitopes to escape immune recognition and clearance. Prior to clearance, however, the streptococcus has the ability to infect other hosts, as shown by the isolation of M protein size variants of a single strain from different patients in a limited outbreak of streptococcal pharyngitis (15) . Therefore, M protein mutants produced in the initial host are able to disseminate this change within the population, leading to the accumulation of changes within the M molecule.
